Edward Nesbitt Wilson, PhD
Affiliations: | 2011-2016 | Pharmacology and Therapeutics | McGill University, Montreal, QC, Canada |
| 2016- | Neurology | Stanford University, Palo Alto, CA |
Area:
Alzheimer's disease,Google:
"Edward Wilson"Cross-listing: Neurotree - Cell Biology Tree
Parents
Sign in to add mentor| Kevin Duffy | research assistant | 2007-2008 | Dalhousie University (Neurotree) |
| A Claudio Cuello | grad student | 2011-2016 | McGill University School of Medicine (Neurotree) |
| Katrin Andreasson | post-doc | 2016- | Stanford University Medical School (Neurotree) |
Collaborators
Sign in to add collaborator| Yogita Chudasama | collaborator | 2010-2016 | McGill (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wilson EN, Wang C, Swarovski MS, et al. (2024) TREM1 disrupts myeloid bioenergetics and cognitive function in aging and Alzheimer disease mouse models. Nature Neuroscience |
| Plastini MJ, Abdelnour C, Young CB, et al. (2024) Multiple biomarkers improve diagnostic accuracy across Lewy body and Alzheimer's disease spectra. Annals of Clinical and Translational Neurology |
| Cruchaga C, Ali M, Shen Y, et al. (2024) Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures for asymptomatic and symptomatic Alzheimer's disease. Research Square |
| Abiose O, Rutledge J, Moran-Losada P, et al. (2023) Post-translational modifications linked to preclinical Alzheimer's disease-related pathological and cognitive changes. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
| Oh HS, Rutledge J, Nachun D, et al. (2023) Organ aging signatures in the plasma proteome track health and disease. Nature. 624: 164-172 |
| Chaney AM, Cropper HC, Jain P, et al. (2023) PET imaging of TREM1 identifies CNS-infiltrating myeloid cells in a mouse model of multiple sclerosis. Science Translational Medicine. 15: eabm6267 |
| Cruchaga C, Western D, Timsina J, et al. (2023) Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer's disease. Research Square |
| Shuken SR, Rutledge J, Iram T, et al. (2023) Publisher Correction: Limited proteolysis-mass spectrometry reveals aging-associated changes in cerebrospinal fluid protein abundances and structures. Nature Aging. 2: 455 |
| Shuken SR, Rutledge J, Iram T, et al. (2022) Limited Proteolysis-Mass Spectrometry Reveals Aging-Associated Changes in Cerebrospinal Fluid Protein Abundances and Structures. Nature Aging. 2: 379-388 |
| Wilson EN, Young CB, Ramos Benitez J, et al. (2022) Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer's disease. Alzheimer's Research & Therapy. 14: 172 |